SPX4,228.48-55.26 -1.29%
DIA337.04-2.88 -0.85%
IXIC12,705.22-260.13 -2.01%

--Atlantic Equities Adjusts Bristol-Myers Squibb's Price Target to $83 from $82, Keeps Overweight Rating

--Atlantic Equities Adjusts Bristol-Myers Squibb's Price Target to $83 from $82, Keeps Overweight Rating

MT Newswires · 07/28/2022 04:50

Please log in to view news